Biomedomics, Inc.

UEI
N2KAPDE8J5D6
CAGE
4LFJ0
Primary NAICS
325413 In-Vitro Diagnostic Substance Manufacturing
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • Minority Owned Business
  • For Profit Organization
  • Asian-Pacific American Owned
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Website
biomedomics.com
Founded
2006
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Biomedomics, Inc.'s 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Rapid, near-patient tests to monitor and guide therapy in sickle cell disease patients Grant · R43HL128670 National Institutes of Health $222,958
Sickle scan(r) - a rapid, qualitative test to aid in the diagnosis of sickle cell disorders Grant · R44HL128670 National Heart Lung and Blood Institute $992,172
TAS::75 0893::TAS multiplexed sensitive testing for drugs of abuse Contract · HHSN271201100019C National Institute on Drug Abuse $745,047
TAS::75 0849::TAS Contract · HHSN261201000083C National Cancer Institute $199,635
TAS::75 0893::TAS multiplexed sensitive testing for drugs of abuse Contract · HHSN271201000012C National Institute on Drug Abuse $99,989

Quick answers

What is Biomedomics, Inc.'s UEI?

Biomedomics, Inc.'s Unique Entity ID (UEI) in SAM.gov is N2KAPDE8J5D6.

What is Biomedomics, Inc.'s CAGE code?

Biomedomics, Inc.'s CAGE code is 4LFJ0.

What is Biomedomics, Inc.'s primary NAICS code?

Biomedomics, Inc.'s primary NAICS code is 325413 (In-Vitro Diagnostic Substance Manufacturing).

Is Biomedomics, Inc. registered in SAM.gov?

Biomedomics, Inc.'s SAM.gov registration expired on November 20, 2018.

What is Biomedomics, Inc.'s most recent federal award?

Biomedomics, Inc.'s most recent federal grant award is Rapid, near-patient tests to monitor and guide therapy in sickle cell disease patients (R43HL128670), from National Institutes of Health, on September 1, 2015.

On GovTribe

See Biomedomics, Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login